AbbVie Corporation, AbbVie Deutschland GmbH & Co. KG and AbbVie Biotechnology Ltd. v. Janssen Inc., 2014 FC 489 (Federal Court of Canada, 29 May 2014)

Case Description

The Canadian Federal Court granted a limited injunction that prevented the defendant from any further marketing activity for an infringing product but allowed the selling of the same infringing product to patients in the absence of an alternative supplier. The decision is important for the treatment of patent holders that do not use their invention (“non-practicing entities”).

Decision Year
Case Summary